This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
One would have thought that suicide is a hard endpoint and that we can believe analyses carried out by drug regulators based on the clinical study reports the manufacturers have submitted to them, but this is not so. FDA 2006; Nov 16. Restoring the two pivotal fluoxetine trials in children and adolescents with depression.
At a cost of 35 million dollars, NIMH’s STAR*D study, which was published in 2006 , is the most extensive and expensive study ever conducted to determine the effectiveness of drug treatment for depression. We showed how STAR*D’s authors had manipulated the data to manufacture fraudulent results.
We organize all of the trending information in your field so you don't have to. Join 5,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
145 
Let's personalize your content